Expression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung Cancer
Open Access
- 16 November 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 96 (22) , 1718-1721
- https://doi.org/10.1093/jnci/djh292
Abstract
Maintenance of p53 function is important for normal cell growth and development, and loss of p53 function contributes directly to malignant tumor development. The recently discovered Pirh2 protein is an ubiquitin–protein ligase that negatively regulates p53 through activity by targeting it for degradation. To determine how Pirh2 may mediate lung tumorigenesis, we evaluated Pirh2 expression in human and mouse lung tumor samples and paired normal lung tissues using immunoblot analysis and immunohistochemistry. Pirh2 protein expression was higher in 27 (84%) of 32 human lung neoplasms than in matched normal lung tissue and in 14 of 15 mouse lung tumors evaluated. In addition, p53 protein was more ubiquitinated in the mouse lung tumors than in normal tissue, and overall p53 expression was lower than that in normal tissue. These results are consistent with the hypothesis that increased Pirh2 expression affects lung tumorigenesis by reducing p53 activity. To our knowledge, this is the first description of altered Pirh2 expression in human and mouse tumors.Keywords
This publication has 23 references indexed in Scilit:
- Protecting p53 from degradationBiochemical Society Transactions, 2003
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Surfing the p53 networkNature, 2000
- p53Cell, 2000
- IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell linesHuman Mutation, 1999
- mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor ProteinMolecular and Cellular Biology, 1996
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Wild-type p53 activates transcription in vitroNature, 1992